Adverse effects of antipsychotic medication in patients with 22q11.2 deletion syndrome: A systematic review

The 22q11.2 deletion syndrome (22q11.2DS) is a multisystem condition and the most prevalent microdeletion syndrome in humans. Approximately 25% of individuals with 22q11.2DS receive antipsychotic treatment. To assess whether patients with 22q11.2DS are vulnerable to adverse effects of antipsychotic...

Descripción completa

Detalles Bibliográficos
Autores principales: de Boer, Janna, Boot, Erik, van Gils, Lissa, van Amelsvoort, Therese, Zinkstok, Janneke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Research Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851664/
https://www.ncbi.nlm.nih.gov/pubmed/31407842
http://dx.doi.org/10.1002/ajmg.a.61324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851664/
https://www.ncbi.nlm.nih.gov/pubmed/31407842
http://dx.doi.org/10.1002/ajmg.a.61324

Ejemplares similares